IPP Bureau
Advanced Enzyme Technologies Q1FY22 consolidated PAT up at Rs. 38.04 cr
By IPP Bureau - August 09, 2021
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
AIkido updates on use of machine learning in drug development orogram
By IPP Bureau - August 09, 2021
The goal for the project is the identification and optimization of anti-viral compounds.
China NMPA approves phase II clinical trial of ASC40
By IPP Bureau - August 09, 2021
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets
By IPP Bureau - August 09, 2021
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
Novavax and Serum Institute submits Emergency Use Authorisation of vaccine to regulatory agencies in India, Indonesia and the Philippines
By IPP Bureau - August 09, 2021
Filing for WHO Emergency Use Authorisation this month
Novavax announces COVID-19 vaccine booster data indicating four-fold increase in neutralising antibodies
By IPP Bureau - August 09, 2021
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
FDA approves Nexviazyme for late-onset Pompe disease
By IPP Bureau - August 09, 2021
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
AstraZeneca Pharma India PAT at Rs 10.24 crores
By IPP Bureau - August 09, 2021
Board declares interim dividend of Rs 2 per equity share
Carbon-based non-toxic and reusable wrapper to increase shelf life of fruits
By IPP Bureau - August 09, 2021
This work has been published in the journal ‘ACS applied materials and interface’
Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia
By IPP Bureau - August 09, 2021
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
Union Minister Sonowal promises AIIA of establishing a Bio-bank in Ayurveda
By IPP Bureau - August 09, 2021
All India Institute of Ayurveda hosts ministers and showcase their achievements
Alkem Laboratories PAT at Rs 468.12 crore for Q1FY22
By IPP Bureau - August 08, 2021
EPS stood at Rs 39.15
Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22
By IPP Bureau - August 08, 2021
Board approves fundraise of Rs 1500 crore
Strides Pharma reports Q1FY22 consolidated loss at Rs 205.2 Cr
By IPP Bureau - August 08, 2021
The company expects revenue growth of 10-15 per cent in the US
Abbott India net profit rises to 8.5 per cent in Q1FY22
By IPP Bureau - August 08, 2021
PAT rises to Rs 195.76 crore
